Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $19.6000 (-2.54%) ($19.4000 - $21.4500) on Mon. Jul. 1, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 28 | Latest Price | $19.6000(-2.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.9% a day on average for past five trading days. | Weekly Trend | ATRA declines -5.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.005% in a week (0% probabilities). VIXM(-35%) VXX(-34%) TLT(-12%) UNG(-6%) IFRA(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | 0 () | Intraday Trend | -6.7% | | | |
|
1 - 5 Day Possible Target | $9.25(-52.81%) | Resistance Level | $21.45 | 5 Day Moving Average | $19.8(-1.01%) | 10 Day Moving Average | $20.55(-4.62%) | 20 Day Moving Average | $21.45(-8.62%) | To recent high | -52.2% | To recent low | 2.9% | Market Cap | $1.456b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |